DESTINY-PANTUMOUR04
Public ClinicalTrials.gov record NCT07124000. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Effectiveness of T-DXd Across HER2-positive Solid Tumors in Patients Who Have Received Prior Systemic Treatment and Have no Satisfactory Alternative Treatment Options: A Hybrid Observational Study
Study identification
- NCT ID
- NCT07124000
- Recruitment status
- Recruiting
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- AstraZeneca
- Industry
- Enrollment
- 100 participants
Conditions and interventions
Conditions
- Adenocarcinoma (NOS)
- Anal Cancer
- Bladder Cancer
- Cervical Cancer
- Endometrial Cancer
- Esophageal Cancer
- Gall Bladder Cancer
- Gastrointestinal Stromal Tumour
- Head and Neck Cancer
- Liver Cancer
- Melanoma
- Mouth Cancer
- Nasopharangeal Cancer
- Neuroendocrine, Gastrointestinal Cancer
- Ovarian Cancer
- Pancreatic Cancer
- Prostate Cancer
- Renal Cell Carcinoma
- Salivary Gland Cancer
- Sarcoma
- Small Cell Lung Cancer
- Testicular Cancer
- Throat Cancer
- Thyroid Cancer
- Urethral Cancer
- Vaginal Cancer
- Vulvar Cancer
Interventions
- Trastuzumab deruxtecan Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 130 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 17, 2025
- Primary completion
- Mar 29, 2028
- Completion
- Mar 29, 2028
- Last update posted
- Apr 30, 2026
2025 – 2028
United States locations
- U.S. sites
- 17
- U.S. states
- 12
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Birmingham | Alabama | 35243 | Recruiting |
| Research Site | Bullhead City | Arizona | 86442 | Recruiting |
| Research Site | Casa Grande | Arizona | 85122 | Recruiting |
| Research Site | San Diego | California | 92123 | Recruiting |
| Research Site | Boulder | Colorado | 80309 | Recruiting |
| Research Site | Coral Springs | Florida | 33065 | Recruiting |
| Research Site | St. Petersburg | Florida | 33714 | Recruiting |
| Research Site | West Palm Beach | Florida | 33401 | Recruiting |
| Research Site | Decatur | Illinois | 62526 | Recruiting |
| Research Site | Topeka | Kansas | 66604 | Recruiting |
| Research Site | Durham | North Carolina | 27708 | Recruiting |
| Research Site | Wilson | North Carolina | 27893 | Recruiting |
| Research Site | Canton | Ohio | 44718 | Recruiting |
| Research Site | Maumee | Ohio | 43537 | Recruiting |
| Research Site | Philadelphia | Pennsylvania | 19104 | Recruiting |
| Research Site | Nashville | Tennessee | 37203 | Recruiting |
| Research Site | Dallas | Texas | 75390 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07124000, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 30, 2026 · Synced May 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07124000 live on ClinicalTrials.gov.